BD Medical, a segment of Medical technology company Becton, Dickinson and Company (BDX) Friday announced 510(k) clearance and the subsequent commercial launch of new passive needle guard technology, BD UltraSafe PLUS. It received FDA clearance as an anti-needlestick safety device.
Commenting on the development, Claude Dartiguelongue, President, BD Medical - Pharmaceutical Systems said, "...We now have an ergonomic safety device solution for those customers seeking to offer patients the ability to manually control their injection."
The company said the product, in addition to offering needlestick safety in an easy-to-use one-handed device, is enhanced with ergonomic features designed to facilitate comfort and support for healthcare providers and patients. Additionally, this safety device is designed to meet increasingly complex biotechnology drug requirements, including higher viscosity, it added.
The company further said The BD UltraSafe PLUS Passive Needle Guard provides many advanced features including a robust plunger rod to help support injection of viscous drugs, a larger drug inspection window to improve drug visibility, extended built-in finger flanges and an enhanced plunger head for improved injection support and stability. These ergonomic improvements are expected to provide support for all users, including patients with diminished manual dexterity.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.